FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108583183> ?p ?o ?g. }

• W2108583183 endingPage "1032" @default.
• W2108583183 startingPage "1023" @default.
• W2108583183 abstract "Reactive hyperemia (RH) in the forearm circulation is an important marker of cardiovascular health, yet the underlying vasodilator signaling pathways are controversial and thus remain unclear.We hypothesized that RH occurs via activation of inwardly rectifying potassium (KIR) channels and Na(+)/K(+)-ATPase and is largely independent of the combined production of the endothelial autocoids nitric oxide (NO) and prostaglandins in young healthy humans.In 24 (23±1 years) subjects, we performed RH trials by measuring forearm blood flow (FBF; venous occlusion plethysmography) after 5 minutes of arterial occlusion. In protocol 1, we studied 2 groups of 8 subjects and assessed RH in the following conditions. For group 1, we studied control (saline), KIR channel inhibition (BaCl2), combined inhibition of KIR channels and Na(+)/K(+)-ATPase (BaCl2 and ouabain, respectively), and combined inhibition of KIR channels, Na(+)/K(+)-ATPase, NO, and prostaglandins (BaCl2, ouabain, L-NMMA [N(G)-monomethyl-L-arginine] and ketorolac, respectively). Group 2 received ouabain rather than BaCl2 in the second trial. In protocol 2 (n=8), the following 3 RH trials were performed: control; L-NMMA plus ketorolac; and L-NMMA plus ketorolac plus BaCl2 plus ouabain. All infusions were intra-arterial (brachial). Compared with control, BaCl2 significantly reduced peak FBF (-50±6%; P<0.05), whereas ouabain and L-NMMA plus ketorolac did not. Total FBF (area under the curve) was attenuated by BaCl2 (-61±3%) and ouabain (-44±12%) alone, and this effect was enhanced when combined (-87±4%), nearly abolishing RH. L-NMMA plus ketorolac did not impact total RH FBF before or after administration of BaCl2 plus ouabain.Activation of KIR channels is the primary determinant of peak RH, whereas activation of both KIR channels and Na(+)/K(+)-ATPase explains nearly all of the total (AUC) RH in humans." @default.
• W2108583183 created "2016-06-24" @default.
• W2108583183 creator A5014957436 @default.
• W2108583183 creator A5057335388 @default.
• W2108583183 creator A5067034463 @default.
• W2108583183 creator A5081692475 @default.
• W2108583183 creator A5084954833 @default.
• W2108583183 date "2013-09-27" @default.
• W2108583183 modified "2023-10-14" @default.
• W2108583183 title "Reactive Hyperemia Occurs Via Activation of Inwardly Rectifying Potassium Channels and Na ⁺ /K ⁺ -ATPase in Humans" @default.
• W2108583183 cites W1546802604 @default.
• W2108583183 cites W1556473910 @default.
• W2108583183 cites W1602344823 @default.
• W2108583183 cites W1603434132 @default.
• W2108583183 cites W1608312877 @default.
• W2108583183 cites W1834249247 @default.
• W2108583183 cites W1891216974 @default.
• W2108583183 cites W1901856024 @default.
• W2108583183 cites W1982580263 @default.
• W2108583183 cites W1990376116 @default.
• W2108583183 cites W2014643180 @default.
• W2108583183 cites W201745967 @default.
• W2108583183 cites W2023313831 @default.
• W2108583183 cites W2025644518 @default.
• W2108583183 cites W2026488016 @default.
• W2108583183 cites W2034409336 @default.
• W2108583183 cites W2036463412 @default.
• W2108583183 cites W2039412500 @default.
• W2108583183 cites W2045096300 @default.
• W2108583183 cites W2045888765 @default.
• W2108583183 cites W2061112342 @default.
• W2108583183 cites W2062845572 @default.
• W2108583183 cites W2095957083 @default.
• W2108583183 cites W2101268933 @default.
• W2108583183 cites W2104721292 @default.
• W2108583183 cites W2109367050 @default.
• W2108583183 cites W2116008500 @default.
• W2108583183 cites W2117372087 @default.
• W2108583183 cites W2136562471 @default.
• W2108583183 cites W2138753146 @default.
• W2108583183 cites W2151478149 @default.
• W2108583183 cites W2160440717 @default.
• W2108583183 cites W2162268316 @default.
• W2108583183 cites W2330001687 @default.
• W2108583183 cites W2404727847 @default.
• W2108583183 cites W3175074590 @default.
• W2108583183 doi "https://doi.org/10.1161/circresaha.113.301675" @default.
• W2108583183 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3871189" @default.
• W2108583183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23940309" @default.
• W2108583183 hasPublicationYear "2013" @default.
• W2108583183 type Work @default.
• W2108583183 sameAs 2108583183 @default.
• W2108583183 citedByCount "85" @default.
• W2108583183 countsByYear W21085831832014 @default.
• W2108583183 countsByYear W21085831832015 @default.
• W2108583183 countsByYear W21085831832016 @default.
• W2108583183 countsByYear W21085831832017 @default.
• W2108583183 countsByYear W21085831832018 @default.
• W2108583183 countsByYear W21085831832019 @default.
• W2108583183 countsByYear W21085831832020 @default.
• W2108583183 countsByYear W21085831832021 @default.
• W2108583183 countsByYear W21085831832022 @default.
• W2108583183 countsByYear W21085831832023 @default.
• W2108583183 crossrefType "journal-article" @default.
• W2108583183 hasAuthorship W2108583183A5014957436 @default.
• W2108583183 hasAuthorship W2108583183A5057335388 @default.
• W2108583183 hasAuthorship W2108583183A5067034463 @default.
• W2108583183 hasAuthorship W2108583183A5081692475 @default.
• W2108583183 hasAuthorship W2108583183A5084954833 @default.
• W2108583183 hasBestOaLocation W21085831831 @default.
• W2108583183 hasConcept C120770815 @default.
• W2108583183 hasConcept C126322002 @default.
• W2108583183 hasConcept C134018914 @default.
• W2108583183 hasConcept C178790620 @default.
• W2108583183 hasConcept C185592680 @default.
• W2108583183 hasConcept C2779133857 @default.
• W2108583183 hasConcept C537181965 @default.
• W2108583183 hasConcept C71924100 @default.
• W2108583183 hasConcept C83743174 @default.
• W2108583183 hasConcept C98274493 @default.
• W2108583183 hasConceptScore W2108583183C120770815 @default.
• W2108583183 hasConceptScore W2108583183C126322002 @default.
• W2108583183 hasConceptScore W2108583183C134018914 @default.
• W2108583183 hasConceptScore W2108583183C178790620 @default.
• W2108583183 hasConceptScore W2108583183C185592680 @default.
• W2108583183 hasConceptScore W2108583183C2779133857 @default.
• W2108583183 hasConceptScore W2108583183C537181965 @default.
• W2108583183 hasConceptScore W2108583183C71924100 @default.
• W2108583183 hasConceptScore W2108583183C83743174 @default.
• W2108583183 hasConceptScore W2108583183C98274493 @default.
• W2108583183 hasIssue "8" @default.
• W2108583183 hasLocation W21085831831 @default.
• W2108583183 hasLocation W21085831832 @default.
• W2108583183 hasLocation W21085831833 @default.
• W2108583183 hasLocation W21085831834 @default.
• W2108583183 hasOpenAccess W2108583183 @default.
• W2108583183 hasPrimaryLocation W21085831831 @default.
• W2108583183 hasRelatedWork W196298946 @default.

• next